TC-6499 (Targacept)

N/A

Report date: 2024/12/23 13:14:57
NME

Base Information

Drug NameTC-6499 (Targacept)
Drug Alias NameTC-6499TC-6499-12
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha3beta4 nicotinic acetylcholine receptor agonists
TargetsAlpha3beta4 nicotinic acetylcholine receptor
Therapy Area/IndicationsNeuralgiaGastroparesisIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTargacept Inc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline PlcTargacept Inc
Inactive CompaniesN/A
Active IndicationsNeuralgia
Inactive IndicationsGastroparesisIrritable Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksN/A